Francisco Arias Horcajadas

Summary

Country: Spain

Publications

  1. ncbi [Sexual dysfunctions induced by serotonin reuptake inhibitors]
    F Arias
    Unidad de Psiqiatría, Fundacion Hospital de Alcorcon, Madrid
    Aten Primaria 26:389-94. 2000
  2. ncbi [Relevance of drug use in clinical manifestations of schizophrenia]
    F Arias Horcajadas
    Unidad de Psiquiatria, Fundacion Hospital Alcorcon, Alcorcon, Madrid, Spain
    Actas Esp Psiquiatr 30:65-73. 2002
  3. ncbi [Psychoactive drugs use in patients with panic disorder]
    F Arias Horcajadas
    Unidad de Psiquiatria, Fundacion Hospital Alcorcon, Alcorcon, Madrid, Spain
    Actas Esp Psiquiatr 33:160-4. 2005
  4. ncbi [Effectiveness and tolerability of addition of risperidone in obsessive-compulsive disorder with poor response to serotonin reuptake inhibitors]
    F Arias Horcajadas
    Unidad de Psiquiatria, Fundacion Hospital Alcorcon, Madrid
    Actas Esp Psiquiatr 34:147-52. 2006
  5. ncbi [Clinical differences between morbid obese patients with and without binge eating]
    F Arias Horcajadas
    Unidad de Psiquiatria, Fundacion Hospital Alcorcon, Madrid
    Actas Esp Psiquiatr 34:362-70. 2006
  6. ncbi [A review about cannabis use like as risk factor of schizophrenia]
    Francisco Arias Horcajadas
    Unidad de Psiquiatria, Fundacion Hospital Alcorcon, Madrid
    Adicciones 19:191-203. 2007
  7. ncbi Cannabinoids in eating disorders and obesity
    Francisco Arias Horcajadas
    Psychiatric Unit, Fundacion Hospital Alcorcon, 28922 Alcorcón Madrid, Spain
    Mol Neurobiol 36:113-28. 2007
  8. ncbi [Cannabinoid system and feeding regulation]
    Francisco Arias Horcajadas
    Unidad de Psiquiatría Fundación Hospital Alcorcón 28922 Alcorcón Madrid
    Adicciones 20:171-83. 2008
  9. ncbi [Evolution of psychopathological alterations in patients with morbid obesity after bariatric surgery]
    Silvia Sánchez Zaldívar
    Departamento de Planificación y Desarrollo de Recursos Humanos, Hospital Universitario Fundacion Alcorcon, Madrid, Espana
    Med Clin (Barc) 133:206-12. 2009

Collaborators

  • A Sanchez
  • Luis Bujanda
  • Silvia Sánchez Zaldívar
  • F Arias
  • Sergio Sánchez Romero
  • Juan José Gorgojo Martínez
  • M T Rivas
  • J J Padín

Detail Information

Publications9

  1. ncbi [Sexual dysfunctions induced by serotonin reuptake inhibitors]
    F Arias
    Unidad de Psiqiatría, Fundacion Hospital de Alcorcon, Madrid
    Aten Primaria 26:389-94. 2000
    ..To assess the incidence of serotonin reuptake inhibitor (SRI) antidepressant-induced sexual dysfunction (SD) and to compare the sexual side effects of SRI...
  2. ncbi [Relevance of drug use in clinical manifestations of schizophrenia]
    F Arias Horcajadas
    Unidad de Psiquiatria, Fundacion Hospital Alcorcon, Alcorcon, Madrid, Spain
    Actas Esp Psiquiatr 30:65-73. 2002
    ..To study the association between drugs use with schizophrenia clinical manifestations...
  3. ncbi [Psychoactive drugs use in patients with panic disorder]
    F Arias Horcajadas
    Unidad de Psiquiatria, Fundacion Hospital Alcorcon, Alcorcon, Madrid, Spain
    Actas Esp Psiquiatr 33:160-4. 2005
    ..The objectives of this study were to evaluate the prevalence of drug use in out-patients with panic disorder and their influence in evolution and therapeutic response of panic disorder...
  4. ncbi [Effectiveness and tolerability of addition of risperidone in obsessive-compulsive disorder with poor response to serotonin reuptake inhibitors]
    F Arias Horcajadas
    Unidad de Psiquiatria, Fundacion Hospital Alcorcon, Madrid
    Actas Esp Psiquiatr 34:147-52. 2006
    ..The objective of this case series was to evaluate effectiveness of risperidone as add on therapy to current SRIs treatment in OCD refractory to treatment patients...
  5. ncbi [Clinical differences between morbid obese patients with and without binge eating]
    F Arias Horcajadas
    Unidad de Psiquiatria, Fundacion Hospital Alcorcon, Madrid
    Actas Esp Psiquiatr 34:362-70. 2006
    ..Our objective was to evaluate clinical differences between morbid obese patients with and without binge eating...
  6. ncbi [A review about cannabis use like as risk factor of schizophrenia]
    Francisco Arias Horcajadas
    Unidad de Psiquiatria, Fundacion Hospital Alcorcon, Madrid
    Adicciones 19:191-203. 2007
    ..These are fundamentally those of users of large quantities of cannabis and those who initiate use in adolescence...
  7. ncbi Cannabinoids in eating disorders and obesity
    Francisco Arias Horcajadas
    Psychiatric Unit, Fundacion Hospital Alcorcon, 28922 Alcorcón Madrid, Spain
    Mol Neurobiol 36:113-28. 2007
    ..Such studies suggest cannabinoid hyperactivity in obesity, and this excessive activity may have prognostic implications...
  8. ncbi [Cannabinoid system and feeding regulation]
    Francisco Arias Horcajadas
    Unidad de Psiquiatría Fundación Hospital Alcorcón 28922 Alcorcón Madrid
    Adicciones 20:171-83. 2008
    ..These studies support a state of cannabinoid hyperactivity in obesity; furthermore, such hyperactivity can constitute a prognostic factor...
  9. ncbi [Evolution of psychopathological alterations in patients with morbid obesity after bariatric surgery]
    Silvia Sánchez Zaldívar
    Departamento de Planificación y Desarrollo de Recursos Humanos, Hospital Universitario Fundacion Alcorcon, Madrid, Espana
    Med Clin (Barc) 133:206-12. 2009
    ....